These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 16433464)

  • 1. [Schizophrenic disorders: current etiologic and clinical knowledge].
    Olié JP; Krebs MO; Lôo H
    Bull Acad Natl Med; 2005 May; 189(5):935-44; discussion 944-7. PubMed ID: 16433464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Psychopathology of schizophrenia and brain imaging].
    Gross G; Huber G
    Fortschr Neurol Psychiatr; 2008 May; 76 Suppl 1():S49-56. PubMed ID: 18461545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Neurological soft signs in schizophrenic patients and their nonaffected siblings].
    Mechri A; Slama H; Bourdel MC; Chebel S; Mandhouj O; Krebs MO; Gaha L
    Encephale; 2008 Oct; 34(5):483-9. PubMed ID: 19068337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Longitudinal progression of movement abnormalities in relation to psychotic symptoms in adolescents at high risk of schizophrenia.
    Mittal VA; Neumann C; Saczawa M; Walker EF
    Arch Gen Psychiatry; 2008 Feb; 65(2):165-71. PubMed ID: 18250254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Schizophrenia, from classification to dimensions: value of longitudinal studies].
    Lecrubier Y
    Encephale; 1997 Apr; 23 Spec No 2():39-43. PubMed ID: 9273306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inefficient neural activity in patients with schizophrenia and nonpsychotic relatives of schizophrenic patients: evidence from a working memory task.
    Karch S; Leicht G; Giegling I; Lutz J; Kunz J; Buselmeier M; Hey P; Spörl A; Jäger L; Meindl T; Pogarell O; Möller HJ; Hegerl U; Rujescu D; Mulert C
    J Psychiatr Res; 2009 Oct; 43(15):1185-94. PubMed ID: 19426993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Schizophrenia: neurodevelopmental disorder or degenerative brain process?].
    Gross G; Huber G
    Fortschr Neurol Psychiatr; 2008 May; 76 Suppl 1():S57-62. PubMed ID: 18461546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interrelated neuropsychological and anatomical evidence of hippocampal pathology in the at-risk mental state.
    Hurlemann R; Jessen F; Wagner M; Frommann I; Ruhrmann S; Brockhaus A; Picker H; Scheef L; Block W; Schild HH; Moller-Hartmann W; Krug B; Falkai P; Klosterkotter J; Maier W
    Psychol Med; 2008 Jun; 38(6):843-51. PubMed ID: 18387213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Schizotaxia--theoretical construct or a tool for clinical research?].
    Parnowska D
    Psychiatr Pol; 2004; 38(5):783-94. PubMed ID: 15523926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Biological markers in schizophrenia].
    Lembreghts M; Ansseau M
    Encephale; 1993; 19(5):501-23. PubMed ID: 8306920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Schizophrenia in childhood and adolescence.
    Mala E
    Neuro Endocrinol Lett; 2008 Dec; 29(6):831-6. PubMed ID: 19112396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The onset of psychiatric disorders and Wilson's disease].
    Benhamla T; Tirouche YD; Abaoub-Germain A; Theodore F
    Encephale; 2007 Dec; 33(6):924-32. PubMed ID: 18789784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective abnormal modulation of hippocampal activity during memory formation in first-episode psychosis.
    Achim AM; Bertrand MC; Sutton H; Montoya A; Czechowska Y; Malla AK; Joober R; Pruessner JC; Lepage M
    Arch Gen Psychiatry; 2007 Sep; 64(9):999-1014. PubMed ID: 17768265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pre-psychotic states--contemporary diagnostic and therapeutic issues. Part II. The biological markers of the risk of schizophrenia. Therapy of pre-psychotic states].
    Szulc A; Czernikiewicz A
    Psychiatr Pol; 2007; 41(1):17-27. PubMed ID: 17494411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Is late-onset schizophrenia related to neurodegenerative processes? A review of literature].
    Lagodka A; Robert P
    Encephale; 2009 Sep; 35(4):386-93. PubMed ID: 19748376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The neurobiological underpinnings of risk and conversion in relatives of patients with schizophrenia.
    Whalley HC; Harris JC; Lawrie SM
    Int Rev Psychiatry; 2007 Aug; 19(4):383-97. PubMed ID: 17671871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Precursors and prodromata of schizophrenia: findings from the Edinburgh High Risk Study and their literature context.
    Owens DG; Johnstone EC
    Psychol Med; 2006 Nov; 36(11):1501-14. PubMed ID: 16817986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics of early psychosis.
    Schothorst PF; Emck C; van Engeland H
    Compr Psychiatry; 2006; 47(6):438-42. PubMed ID: 17067866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent advances in the biological study of personality disorders.
    New AS; Goodman M; Triebwasser J; Siever LJ
    Psychiatr Clin North Am; 2008 Sep; 31(3):441-61, vii. PubMed ID: 18638645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.